UNSPSC 85293306: Diagnosis of glaucoma secondary to drugs

This classification denotes the group of activities that yields a diagnosis of Glaucoma secondary to drugs. Glaucoma secondary to drugs is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code H40. 6

UNSPSC 85293306 Diagnosis of glaucoma secondary to drugs is a Commodity code that nominally describes clinical diagnostic services for drug-induced glaucoma. However, the most recent state and local opportunities posted under this code do not reflect this scope; instead, they encompass diagnostic imaging systems procurement, special education contracted services, and temporary health professional staffing across multiple ancillary clinical categories. The code shows a significant mismatch between its stated commodity definition and the work actually being solicited by state and local bodies. When interpreted against recent procurement activity, the code carries little signal for vendors seeking opportunities in drug-induced glaucoma diagnosis or related ophthalmology services.

The three most recent opportunities tagged to this code span different issuing bodies and geographies: San Mateo Medical Center (a county public hospital in California) issued an RFP on October 7, 2026 for a Diagnostic Imaging PACS with a response deadline of October 21, 2026; Birdville Independent School District (northeast Tarrant County, Texas) posted a competitive sealed proposal request on September 18, 2026 for special education contracted services due October 21, 2026; and Santa Clara County Health System (California) released a qualification vehicle on July 7, 2026 for temporary health professional staffing with a response deadline of October 7, 2026. None of these solicitations involve ophthalmology, glaucoma diagnosis, or pharmaceutical-related clinical services. The code appears to have received incorrect tagging at the source, and state and local procurement professionals should treat activity under UNSPSC 85293306 as unreliable for targeting genuine opportunities in drug-induced glaucoma diagnosis or related clinical work.